ScholarGate
Msaidizi

Linganisha mbinu

Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.

Pharmacovigilance PRR/ROR×Uundaji wa Kimodelia wa Madhara ya Dawa kwa Idadi ya Watu×
NyanjaFamakolojiaFamakolojia
FamiliaProcess / pipelineProcess / pipeline
Mwaka wa asili20021992
MwanzilishiArne Melander and colleaguesLewis Sheiner and Stephen Roush
Ainasafety signal detectiondose-response modeling
Chanzo asiliaSzarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗
Majina mbadalaPRR, ROR, signal detection, adverse event monitoringPopPD, population PD, hierarchical PD modeling
Zinazohusiana33
MuhtasariProportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation.Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.
ScholarGateSeti ya data
  1. v1
  2. 2 Vyanzo
  3. PUBLISHED
  1. v1
  2. 2 Vyanzo
  3. PUBLISHED

Nenda kwenye utafutaji Pakua slaidi

ScholarGateLinganisha mbinu: Pharmacovigilance PRR/ROR · Population Pharmacodynamics. Imepatikana 2026-06-20 kutoka https://scholargate.app/sw/compare